Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Endocarditis I: Introduction

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

Endocarditis III: Medical Management

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

Endocarditis IV: Nursing Management

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...

Diphtheria

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infection.

Open forum infectious diseases·2022

Same author

Validity of 2020 vancomycin consensus recommendations and further guidance for practical application.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2021

Same author

Questions on Vancomycin Dosing.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020

Same author

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020

Same author

Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Pharmacotherapy·2020

Same author

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2020

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Clinical experience with daptomycin: bacteraemia and endocarditis.

Donald P Levine¹

¹Division of General Internal Medicine, Wayne State University, University Health Center, Detroit, MI 48201, USA. dlevine@med.wayne.edu

The Journal of Antimicrobial Chemotherapy

|October 10, 2008

Summary

Daptomycin is an effective treatment for serious Staphylococcus aureus infections, including methicillin-resistant strains. This antibiotic shows comparable outcomes to vancomycin with reduced kidney toxicity.

More Related Videos

In Vivo Mouse Model of Spinal Implant Infection

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Jun 29, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

In Vivo Mouse Model of Spinal Implant Infection

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

Area of Science:

Infectious Diseases
Pharmacology
Microbiology

Background:

Serious Staphylococcus aureus infections, particularly methicillin-resistant S. aureus (MRSA), pose a significant clinical challenge.
Vancomycin, the traditional treatment, exhibits slow bactericidal activity and increasing minimum inhibitory concentrations (MICs), driving the need for alternative therapies.

Purpose of the Study:

To evaluate the efficacy and safety of daptomycin as a treatment for Gram-positive bacterial infections.
To compare daptomycin's outcomes and nephrotoxicity against vancomycin or beta-lactam in combination with an aminoglycoside.

Main Methods:

Review of studies investigating daptomycin for various Gram-positive infections.
Analysis of a randomized controlled trial comparing daptomycin monotherapy with combination therapies.

Main Results:

Daptomycin demonstrated efficacy in treating bacteremic infections caused by staphylococci and vancomycin-resistant enterococci.
The randomized trial showed daptomycin achieved outcomes comparable to vancomycin/beta-lactam plus aminoglycoside.
Daptomycin exhibited significantly lower nephrotoxicity compared to the combination therapies.

Conclusions:

Daptomycin represents a promising alternative for treating serious Gram-positive infections, including MRSA.
Its favorable safety profile, particularly reduced nephrotoxicity, makes it a valuable therapeutic option.